In silico, 6lu7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2

Basit Öğe Kaydı
dc.authorscopusid57210844522
dc.authorscopusid24923510500
dc.authorscopusid8235840100
dc.authorscopusid7004135227
dc.authorscopusid12786703000
dc.contributor.authorÖzdemir, Mücahit
dc.contributor.authorKöksoy, Baybars
dc.contributor.authorCeyhan, Deniz
dc.contributor.authorBulut, Mustafa
dc.contributor.authorYalçın, Bahattin
dc.date.accessioned2022-05-11T14:31:04Z
dc.date.available2022-05-11T14:31:04Z
dc.date.issued2020
dc.departmentFakülteler, Fen Edebiyat Fakültesi, Kimya Bölümü
dc.description.abstractThe new emerging coronavirus (SARS-CoV-2) has become a global health problem with very rapid transmission from person to person, causing severe acute respiratory problems. In the circumstance, the discovery of vaccines or drugs to eradicate or reduce the impact of the COVID-19 has made it imperative to develop new approaches. In the current situation, many drugs on the drug bank have been researched computationally, and there has not been an emphasis on synthetic effort. We tested 42 coumarin derivatives (1a-14c) containing 14 different substituents, which are secondary metabolites of plants, and the anticoagulant Coumadin (warfarin) drug as a reference by Molecular Docking calculation technique on 6LU7 main protease of the coronavirus. Optimized geometries, electron motions and energy values of all coumarins were also determined using the Density Functional Theory (DFT) method. The drug properties of coumarins were estimated using the ADME-Tox test method. Coumarins formed strong interactions with HIS41, CYS145, and other amino acids in the active site of the main protease. In general, 6,7-dihydroxy-3-phenylcoumarin derivatives gave relatively higher scores, and for all coumarins, biphenyl (for 10a,-8.6 kcal/mol; 10b,-8.3 kcal/mol; 10c,-7.9 kcal/mol) and 4-trifluoromethylphenyl (for 13a,-8.1 kcal/mol; 13b,-8.1 kcal/mol; 13c-8.3 kcal/mol) substituted coumarin had the highest score. The coumarins data reported in this study serves as a stepping stone for in vitro and in vivo experimental research for vaccine development purposes. © 2020, Turkish Chemical Society. All rights reserved.
dc.identifier.doi10.18596/jotcsa.753157
dc.identifier.endpage712
dc.identifier.issn2149-0120
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85090663639
dc.identifier.scopusqualityQ4
dc.identifier.startpage691
dc.identifier.urihttps://doi.org/10.18596/jotcsa.753157
dc.identifier.urihttps://hdl.handle.net/20.500.11776/7302
dc.identifier.volume7
dc.indekslendigikaynakScopus
dc.institutionauthorCeyhan, Deniz
dc.language.isoen
dc.publisherTurkish Chemical Society
dc.relation.ispartofJournal of the Turkish Chemical Society, Section A: Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCoumarins
dc.subjectCOVID-19 main protease
dc.subjectDrug design
dc.subjectMolecular docking
dc.subjectSARS-CoV-2
dc.titleIn silico, 6lu7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
7302.pdf
Boyut:
3.83 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Fen Edebiyat Fakültesi Koleksiyonu